dokumendiregister.ee
Sissetulev kiriAvalik

Farmakopöa tööplaani asjus

Ravimiamet · 17. mai 2024
Viit
REP-1/1809-1
Registreeritud
17. mai 2024
Dokumendi liik
Sissetulev kiri
Adressaat
European Directorate for the Quality of Medicines & HealthCare
Saabumis/saatmisviis
e-post
Funktsioon
REP Euroopa Farmakopöaga seotud asjaajamine
Sari
REP-1 Euroopa Farmakopöa alane kirjavahetus
Toimik
REP-1/2024
Vastutaja
Signe Leito (RA, Labor)

Failid

Sisu (failidest)

Signe Leito Saatja: [email protected] Saatmisaeg: reede, 26. aprill 2024 15:39 Adressaat: Signe Leito Teema: For action: Proposed addition to the work programme of Group 17 - Sitagliptin malate: EDQM-2024-01782-mail Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Please make sure to include in any reply our mail reference: EDQM-2024-01782-mail **************************************************************************** For the attention of NPAs Copy: Presidium Dear Colleagues, Please find below the link to a survey being carried out concerning the proposed addition of Sitagliptin malate to the work programme of Group 17. In order to have access to the survey, please copy and paste the link into your Internet browser: https://survey.edqm.eu/index.php?r=survey/index&sid=733794&newtest=Y&lang=en Deadline for replies: 29 May 2024 Thank you. With kind regards On behalf of Isabelle Mercier Villy Nikolova Administrative Support Assistant European Pharmacopoeia Department EDQM Council of Europe Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71 https://www.edqm.eu / https://www.edqm.eu/store Stay connected with the EDQM 1 **************************************************************************** Please make sure to include in any reply our mail reference: EDQM-2024-01782-mail 2
Allikas: Ravimiamet dokumendiregister →